Guess which ASX 200 stock's founders just sold $176m of shares

Should you be concerned by this insider selling?

| More on:
Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As I mentioned here yesterday, insider selling is often regarded as a bearish indicator.

That's because if insiders believed that their shares were undervalued and destined to rise, they wouldn't part ways with them.

So, should owners of Pro Medicus Limited (ASX: PME) shares be concerned that their founders have just sold down their holdings?

What's happening?

According to an announcement, the ASX 200 stock's co-founders, Dr Sam Hupert and Anthony Hall, have each sold 1 million Pro Medicus shares during the current trading window.

Dr Hupert and Hall received an average of $88.02 per share, which equates to a total consideration of approximately $88 million each or $176 million combined.

The good news for shareholders is that demand for these shares was evidently very strong because the sale was undertaken at market price and represents only a 1.5% discount to the ASX 200 stock's record high.

As a comparison, the beleaguered tech stock Appen Ltd (ASX: APX) is currently attempting to raise $30 million from investors at a whopping 42.1% discount to its last close price.

Why are they selling this ASX 200 stock?

The company explained that the sale was made after the founders were approached by an individual fund. It said:

The Pro Medicus Board has been advised that co-founders Dr Sam Hupert and Mr Anthony Hall have sold 1 million shares each in the current trading window representing less than 4% of their individual holdings. The sale was in response to a strong approach from an individual fund and was done before market at the previous day's closing price (0% discount).

Should you be concerned?

While insider selling doesn't usually go down well with the market, it is important to put things into perspective.

Firstly, the company notes that the two founders remain "actively engaged in the company as executives and board members and are committed to its future."

Furthermore, "they remain the two key stake holders in the company with their combined holding post this recent sale of 48%." Clearly their interests remain firmly aligned with shareholders.

It is also worth highlighting that both founders have "re-affirmed that they do not intend to sell any further shares in PME in the foreseeable future."

This ASX 200 stock is up more than 50% over the last 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Appen and Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A man clenches his fists in excitement as gold coins fall from the sky.
Technology Shares

Guess which ASX 300 tech stock is jumping 11% on big news

Let's see what is getting investors excited about this tech stock today.

Read more »

Five people in an office high five each other.
Technology Shares

5 best performing ASX 200 tech shares of FY25

Some of the technology sector's biggest names led the charge in share price growth last financial year.

Read more »

Happy man and woman looking at the share price on a tablet.
Technology Shares

Tech takeover – two Aussie technology shares to watch

These two tech shares could be undervalued according to this broker. 

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Technology Shares

Guess which ASX tech stock is racing higher on big news

This tech stock is making a key acquisition.

Read more »

drone technology, drone defence, woman operating drone
Technology Shares

Was it a good idea to buy DroneShield shares in FY25?

Did this counter drone technology company deliver the goods for investors? Let's find out.

Read more »

Broker looking at the share price.
Technology Shares

Can the Xero share price deliver a 17% return after the US acquisition?

Can investors generate strong returns after Xero’s US acquisition?

Read more »

A corporate female in a suit stands in front of a huge holographics virtual reality screen with shapes and lights and pictures
Technology Shares

Bell Potter names the best ASX tech stocks to buy in FY 2026

Looking for tech sector exposure? These shares could be worth considering.

Read more »

Man on computer looking at graphs
Technology Shares

$8,000 invested in Xero shares 1 year ago is now worth…

Xero shares have raced ahead of the benchmark over the past year.

Read more »